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Introduction
For drugs of abuse, hair analysis complements blood and urine analyses by providing long-term information on an individual's drug use and is routinely applied in clinical and forensic toxicology (1, 2) . Segmental hair analysis is discussed to provide useful information on the state and history of drug dependence. Several studies have analyzed opiates in hair to prove the : illicit consumption of heroin (HER) and distinguish HER abuse from morphine (MOR) or codeine (COD) use (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . HER abuse can be determined by the detection of HER by itself or by the detection of 6-monoacetylmorphine (MAM)--the major heroin metabolite found in hair--and MOR. However, hair analysis does not necessarily deliver conclusive data on the relationship between intake doses and determined drug concentrations. Obstacles to the determination of such relationships are individually different hair growth rates, cosmetic hair treatments, and, most importantly, incorrect and often low dosages that are self-reported by drug abusers (13) . Furthermore, the unknown purity of the illicit compounds, a considerable variation in uptake of drug from blood to hair as well as the rate of sweating, the amount of apocrine and sebaceous gland secretions between individuals, have to be considered. These factors result in a very low correlation between dose and analyzed concentration. Analysis of hair samples from 20 subjects taking part in a HER-maintenance program revealed a weak correlation between the doses of administered HER and the concentrations of total opiates in hair (r = 0.346) (13) . The correlation coefficients increased from r --0.12 to 0.25 and 0.64 for HER, MAM, and MOR, respectively.
In the present study, we analyzed hair samples from 46 subjects who, as participants in the German HER-maintenance program, received daily prescribed doses of HER hydrochloride via intravenous administration, under the control of medical staff. The aim of the study was to provide information on possible dose-concentration relationships, but also the effect of varying doses on single individuals. One of the crucial issues that arises in HER-maintenance programs is whether the patients continue to consume illicit HER in addition to the administered doses of the pharmaceutical drug. Acetylcodeine (AC), a manufacturing impurity of illicit HER, may be used as a specific marker of illicit HER abuse because pharmaceutical HER does not contain this compound (14, 15) . Therefore, the determination of AC was included in this study.
Additionally, the determined opiate concentrations in hair obtained from patients, which were HER-treated under medical control, were compared with the results revealed from a collective of opiate-associated fatalities.
Materials and Methods

Reagents and materials
The substances HER, HER-dg, MAM, MAM-d3, MOR, MOR-d3, COD, and COD-d3 were purchased as stock solutions (1 mg/mL) from Promochem (Wesel, Germany), and AC and AC-d3 were obtained as stock solutions (1 mg/mL) from Lipomed (Bad Saeckingen, Germany). All reagents were stored at 8~ and used after dilution to the required concentrations. Further chemicals were analytical grade and purchased from Merck (Darmstadt, Germany). Chromabond Drug solid-phase extraction columns (3 mL, 200 mg) and N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) were supplied by Macherey-Nagel (Dfiren, Germany).
Gas chromatography-mass spectrometry (GC-MS) method
The hair analyses were performed on a model 6890 series Plus GC, in combination with an Agilent 5973 N MSD MS (Chromtech, Idstein, Germany). Substances were separated on a fused-silica capillary column (HP-5MS, 30 m x 0.25-ram i.d., 0.25-1~m film thickness). The temperature program applied was as follows: 180~ maintained for 1 rain, 15~ increase up to 190~ 190~ maintained for 10 rain, 5~ increase up to 250~ with following 30~ increase up to 290~ (2 rain); the total run time was 21.28 rain. The temperatures for the injection port, ion source, quadrupole, and interface were set at 280~ 230~ 150~ and 290~ respectively. Injection was carried out in splitless injection mode, and helium at a flow rate of 1.0 mL/min was used as the carrier gas.
Electron impact (EI) mass spectra for each of the analytes were recorded in full scan mode, in order to detect the characteristic mass fragments. For each analyte, the three most intense ions were chosen for selected ion monitoring (SIM) mode: (232, 344, 285) . For quantification purposes, area calculation was performed using the mass traces of the SIM ions indicated in bold print. Evaluation was carried out by calculating the peak-area ratios of the analytes and the deuterated internal standards as a function of the substance concentration. Figure 1 shows authentic chromatograms.
Specimen collection
Hair specimens were collected from 46 caucasian subjects, who, under controlled conditions in the German HER-maintenance program in Bonn, self-administered HER hydrochloride intravenously on a regular basis. Participants of the study were selected far in advance, allowing for a prospective collection of hair samples (T-l). Hair specimens were obtained from the patients enrolled in the HER-maintenance program one month prior to commencement of the treatment (T-l) and after one year of participation in the program (T12). Heroin was administered twice or thrice daily, with the daily doses varying between 10 and 1000 rag.
The hair samples were obtained by cutting off strands of hair as closely as possible to the scalp with a pair of scissors. Then they were fixated with a piece of string, rolled into aluminum foil, and marked at the scalp end. Note was taken of special hair treatment procedures, such as bleaching or cosmetic treatment with dye or other chemicals. The samples were stored at room temperature in a dry place, and analysis took place within two years of acquisition.
Hair samples from opiate-associated fatalities (n = 24) were obtained during postmortem examination in the same way as described.
Proximal hair segments of 1-cm length were analyzed in both subject groups. Additionally, hair samples of sufficient length (> 12 cm) from the HER-treatment patients were cut completely into segments (segment length 2 cm) in order to be able to determine dose-concentration relationships in view of the entire treatment period.
Sample preparation
The hair specimens were washed successively for 5 min with 5 mL of deionized water, petroleum benzene, and dichloromethane. Subsequently, the specimens were dried, and the segments prepared for analysis by cutting them into smaller segments approximately 1 mm in length. The washing solutions were analyzed by conventional GC-MS procedures to exclude contamination. Only few hair samples showed positive washing solutions, these samples were cleaned once more as de- T-l, grey line: T12), the masses used for quantification are overlaid manually. At ]-1, HER, MAM, MOR, COD, and AC were present. At T12, only HER, MAM, and MOR were detected, indicating that no illicit HER additionally was used. HER scribed until negative results were obtained.
After addition of 8 mL of methanol and 50 pL of each deuterated internal standard (5 pg/mL) to 50 mg of hair, the extraction was performed by ultrasonicating for 5 h at 50~ Following this procedure, the samples were evaporated to dryness under a stream of nitrogen and reconstituted in 2 mL of phosphate buffer (pH 6).
All solid-phase extraction columns were conditioned with 2 mL of methanol, deionized water, and phosphate buffer, sequentially. Following the dispensation of samples, the columns were rinsed with 1 mL water, 1 mL 0.1M phosphoric acid (twice), and 1 mL of methanol. The elution was performed with 2 mL of dichloromethane/propanol-2/ammonia (80:20:2).
The elution solution was evaporated, and the extract was derivatized by adding 70 pL of MSTFA with 30 lJL of pyridine and 100 I~L of iso-octane, and allowed to incubate for 15 rain at 90~ A 1-pL aliquot was injected into the GC-MS system.
For preparation of the standard and internal standard solutions, 100 IJL of the stock solutions (1 mg/mL) were diluted 1:200 in acetonitrile. The obtained standard solutions (5 pg/mL) were used for calibration (e.g., 50 pL for 250 ng absolute concentration). Calculations were compared to weighed samples of 50 mg hair.
Validation protocol and statistics
The method was fully validated according to international guidelines using the program VALISTAT ~ for statistics (16) .
In order to evaluate method selectivity, blank hair samples from different sources were prepared as described, but without adding any analytes or internal standards (n = 6). Furthermore, blank samples were analysed to verify the absence of analyte ions in the respective peaks of the internal standards (n = 2). No matrix effects were found.
For calibration blank hair samples were spiked with analytes in equidistant concentrations. Replicates of all standard samples were processed as described above, checked for outliers (Grubbs-Test) and averaged (n = 6). Using the mean values, calibration curves were checked for variance homogeneity (F-Test) and for linearity (Mandel-Test). Results showed that the analytes AC, HER, and MOR demonstrated a linear behaviour throughout the whole range (0.5-25 ng/mg). For the analytes MAM and COD two linear calibration curves, one each for a high concentration and low concentration range, were established. Table I contains both linear calibration curves as well as the corresponding correlation coefficients. For the determination of analytical limits [limit of detection (LOD), limit of quantitation (LOQ)] blank hair samples were spiked with 10 calibration standard mixes near the expected LOD. These samples were processed and analyzed in duplicate as described. LOD and LOQ values were determined by VALISTAT using mathematical algorithms and refer to an amount of 50 mg of hair.
Additionally, three quality control (QC) samples (high, medium, and low concentrations of 25 ng/mg, 5 ng/mg, and 0.5 ng/mg, respectively) were prepared and analyzed in duplicate over 8 days. The values obtained were used to determine intraday and interday precision (P), as well as accuracy (A) ( Table  II) . For the detection of the recovery, six samples each in high and low concentrations were extracted as described above and recoveries were calculated using six non-extracted samples in high and low concentrations (Table I) .
In previous studies, the problem of a possible degradation of Figure 2 ). Additionally, degradation of HER, MAM, and their corresponding internal standards during sample preparation was evaluated. For this purpose, four blank samples were spiked separately with each analyte (HER, HER-dg, MAM, and MAM-d3). Of these, two samples were prepared as described, and the other two samples were prepared as described but without ultrasonicating. The decomposition of HER and MAM to MOR as well as HER-d9 and MAM-d3 to MOR-d3 was shown to be less than 5%.
All data were evaluated using the computer program SPSS (SPSS, Inc., Chicago, IL). A statistical significance was assumed below the 0.05 probability level 9 Groups of cases were corn- pared using t-and Wilcoxon-tests. The applicability of the detailed procedures was proven by the successful participation in interlaboratory tests and by routine analysis of standard reference materials.
Results and Discussion
Various preparation techniques have been developed to analyze hair specimens for opiates, such as organic solvent incubation (6, 7, (17) (18) (19) (20) (21) (22) (23) (24) , enzymatic hydrolysis (25, 26) , and acid (27) (28) (29) (30) , or alkaline hydrolysis (31) . For the current study, the latter has to be avoided because of alkaline hydrolysis of HER and 6-MAM to MOR (10,32) 9 Methanolic extraction revealed the best results and is the unique procedure that has been proposed to identify HER in hair. For this reason we used a procedure with methanolic ultrasonication and further clean-up for the simultaneous determination of HER, 6-MAM, MOR, COD, and AC. The analytical parameters used are described in the validation protocol 9 There was no substantial decomposition of HER or 6-MAM during sample preparation and analysis 9
The concentrations determined in the proximal hair segment (T-1 and T12) ranged between 0.04 and 1.16 ng/mg for HER, between 0.02 and 32.41 ng/mg for MAM, and 0.03 and 11.79 ng/mg for MOR (Table III) . There were no statistically significant differences in the mean drug concentrations determined for T-1 and T12 in all subjects. Doses of HER at T12 stage were similar to the doses the patients administered before admission to the HER maintenance program. Except for 23 cases (25%; 6 T-l; 17 T12), MAM was the major analyte present in hair. MOR was present in the hair samples from the remaining cases in higher concentrations than MAM, probably due to hydrolysis before sample preparation. In no case was HER the major analyte. tested positive for HER, a result which was also observed by other authors with detection rates of 14% (7), 27% (20), 35% (6), and 50% (33) . In only one report, 90% of the samples tested positive for HER (13) . In the present study MAM was detected in all HER users' hair, MOR in 87% and 89.1% of the cases (T-1 and T12).
A correlation between the intake dose and the total opiate concentration in the subjects' hair at T12 could be established for drug users who were administered prescribed doses of heroin (r = 0.66, p = 0.003) (Figure 3) . In accordance with the corresponding plasma halflife increasing coefficients of correlation could be determined for the analysis of each substance (r = 0.42, 0.59, and 0.69, p --0.262, 0.081, and 0.001 for HER, MAM, and MOR). In comparison to the results of Kintz et al. (13) (r = 0.12, 0.25, and 0.64 for HER, MAM, and MOR) we found higher correlation coefficients, while confirming the finding that MOR, with the highest plasma half-life, leads to the highest correlation coefficient. Cases in which we could not rule out a parallel consumption of illegal HER (detection of COD or AC in 13% and 10.9% of the patients, respectively) were deleted and preliminary dose-concentration correlations were performed. The questionable cases were compared with the data set of the remaining cases, and there were no significant differences, hence statistics were then performed using all patient data. In all possible cases (n = 28), where the length of the hair sample permitted segmental analysis (length between 10 and 22 cm), the hair was cut in 2-cm sections starting from the root end. The segmental drug concentrations were compared with the drug histories of patients who administered changing doses of prescribed HER. Figure 4 shows two examples of the segmental analysis of HER users' hair. The lack of correlation between HER administration and opiate concentrations found in the hair shown in this figure is representative for all examined cases. The continued administration of higher doses to a patient did not lead to a continuous increase of analyte concentration in the hair, nor was it possible to confirm a decrease in concentration at a constant dosage. The absence of conclusive resuits leads us to suggest that segmental hair analysis should not be used to determine a timed dose-concentration relationship. In general, MOR, which shows a much longer half-life than HER in plasma and tissues and a significant amount of accumulation, indicated a possible dose-concentration relationship. However, other parameters such as individual hair growth rates and the stability of drugs in hair have to be taken into account. For example, we never found the analyte HER in colored hair, which could be evidence for a possible hydrolysis of HER during cosmetic treatment. Furthermore, a considerable variation in the uptake of drug from blood to hair, the rate of sweating and the amount of apocrine and sebaceous gland secretions between individuals result in a low correlation between dose and concentration. COD and AC have been suggested as markers of illicit heroin abuse. COD is a natural constituent of illicit heroin preparations isolated from Papaver somniferurn L., which is subjected to acetylation and purification. However, with respect to MOR or COD containing medicines or other sources of opium alkaloids (e.g., poppy seeds), patients of a HER-maintenance program are advised to not ingest any MOP/COD-containing medicines and to not consume foods containing poppy seeds. In contrast to COD, only AC is suggested as absolute specific marker of illicit HER. The AC content in illicit heroin ranges from 0.25 to 10.2% (34) . The pharmaceutical medication HER is pure. Therefore, the presence of COD and especially of AC in samples of patients indicate that they may be supplementing their prescribed HER doses with non-prescription heroin. In the present study, COD and AC were detected in 50% and 43.5% of samples at T-1 (one month before pharmaceutical HER was administered). These findings correspond to hair from opiate-associated fatalities, where AC was detected in 44% and COD in 66% of the cases (14) . Neither AC nor COD was identified in hair collected from addicts taking part in the Swiss HER-maintenance program in Berne (14) . In our present study, after one year of participating in the HER-maintenance program, COD and AC were found in 13% and 10.9% of the samples, respectively. In a similar study testing opiate concentrations in hair of patients who participated in a HERmaintenance program in Geneva (Switzerland), COD was detected in 32.6% of the samples and AC in 11.6% (15) , which corresponds to our results. In hair of illicit HER users COD and AC detection rates were extraordinarily high with 94.5% and 91.8%, respectively, using a method with an LOQ of 0.09 ng/mg.
Comparing opiate concentrations in hair from HER-treated patients with the results from a collective of opiate-associated fatalities revealed no statistically significant differences in the mean values, except for HER (Table IV) . However, the detection rate of HER with 8.3% was much lower, probably due to the fact that hair samples collected at autopsy were often wet and hydrolysis during storage could not be excluded. The detection rates of COD and AC (33.3% and 16.7%) were in the same range as in the HER-treated patients at T-1. Other groups found significantly lower MOR concentrations in opiate-related fatalities than in active drug abusers or previous abusers who had been abstinent for a number of months. This raised the question, whether a decreased tolerance due to abstinence might be a leading cause of death in these cases (35) . Additionally, the danger of overdosing was considered to be higher in periodical abusers, who, due to the occasional nature of their habit, appear to lack high levels of tolerance. Unfortunately, no MAM concentrations were evaluated in this study. Elsewhere it was described that current HER users had a median hair MOR concentration four times higher than that of fatal overdose cases, indicating substantially heavier recent opiate use (36) . The fatal overdose cases were reported to have been at risk because of lower tolerance to opiates and a higher level of alcohol consumption. The median values for MOR in our studies were 0.25 ng/mg for the fatal overdose cases, as opposed to 0.41 ng/mg for the participants of the heroin maintenance program. In contrast to the cited MOR concentration-relationship of 1:4 between fatal overdose cases and current users, we found a ratio of 1:1.33, which has to be considered an insignificant change. This insignificance becomes more obvious considering the mean values of MOR concentrations: in fatal overdose cases a mean of 1.15 ng/mg in contrast to 1.46 ng/mg in heroin maintenance patients (ratio of 1:1.26). This suggests that the fatal cases are not the consequence of an accidental overdose due to a lack of tolerance. In comparison to Kronstrand et al. (37) , who could not detect any opiates in 6 of 19 cases, no such complete opiate abstinence prior to the fatal drug-overdose could be observed in our study. This debases the conclusion of Tagliaro et al. (35) that a sudden reuptake of heroin consumption from total abstinence has to be considered the crucial factor in overdose death. However, it should not be ignored that these results are solely based on opiate detection in hair, whereas other matrices were not considered. Figure 5 shows the relationships between the concentrations of COD and AC to that of MAM and MOR in hair of the T-1 patients and the opiate-associated fatalities. The correlation coefficients increased from r = 0.78, to r = 0.82, and r = 0.89 and remained at r = 0.89 comparing AC with MOR, COD with MOR, AC with MAM, and COD with MAM, respectively. The highest concentrations of MAM and MOR in hair (32.41, 30.01 and 11.79, 11.87 ng/mg) have been excluded because these data points had an excessive weight in the statistical analysis. Others have shown that with a MAM concentration of 0.3 ng/mg, a corresponding AC concentration of up to 0.2 ng/mg could be measured (15) . In a single case this corresponds to our results: at a MAM concentration of 0.33 ng/mg we found AC (0.04 ng/mg), although this concentration was below the LOQ. The lowest AC concentration above the LOQ was 0.18 ng/mg with a MAM concentration of 5.24 ng/mg. Generally, we found much lower concentrations of AC compared to the observations of Kintz et al. (14) . Unlike MAM, AC can not be considered a suitable biomarker in hair analysis following HER abuse because of its low concentration and its absence in about 50-60% of specimens that tested positive for MAM. However, AC is a interesting biomarker of illicit HER consumption during the course of HER-maintenance programs.
Conclusions
The results disagree with the observations of Kintz et al. (13) , who found only limited dose-concentration relationships in hair after HER abuse. The correlation is influenced by the plasma half-lifes of analytes. The lack of differences between measured opiate concentrations in the hair of participants in a controlled heroin-maintenance program and of opiate-associated fatalities does not support the hypothesis that a lack of tolerance can be regarded as the major cause of death. In addition, the absence of AC in the majority of the opiate-related deaths questions its applicability as a characteristic marker of the consumption of illicit heroin.
